Ridruejo E - Search Results

1

'Real-life' experience with direct-acting antiviral agents for HCV after kidney transplant.

Fabrizi F, Alonso C, Palazzo A, Anders M, Reggiardo MV, Cheinquer H, Zuain MGV, Figueroa S, Mendizabal M, Silva M, Ridruejo E; Latin American Liver Research, Educational and Awareness Network (LALREAN). Fabrizi F, et al. Among authors: ridruejo e. Ann Hepatol. 2021 Nov-Dec;25:100337. doi: 10.1016/j.aohep.2021.100337. Epub 2021 Mar 5. Ann Hepatol. 2021. PMID: 33684523 Free article.

2

[Statement of the Argentinian Concensus on Hepatitis C 2007].

Fassio E, Schroder T; Asociación Argentina para el Estudio de las Enfermedades del Hígado. Fassio E, et al. Acta Gastroenterol Latinoam. 2008 Mar;38(1):56-74. Acta Gastroenterol Latinoam. 2008. PMID: 18533358 Spanish. No abstract available.

3

Efficacy, tolerability and safety in the treatment of chronic hepatitis C with combination of PEG-Interferon - Ribavirin in daily practice.

Ridruejo E, Adrover R, Cocozzella D, Fernández N, Reggiardo MV. Ridruejo E, et al. Ann Hepatol. 2010 Jan-Mar;9(1):46-51. Ann Hepatol. 2010. PMID: 20308722 Free article.

4

Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C.

Ridruejo E, Díaz C, Michel MD, Soler Pujol G, Martínez A, Marciano S, Mandó OG, Vilches A. Ridruejo E, et al. Ann Hepatol. 2010 Jul-Sep;9(3):271-7. Ann Hepatol. 2010. PMID: 20720267 Free article.

5

Thioctic acid-induced acute cholestatic hepatitis.

Ridruejo E, Castiglioni T, Silva MO. Ridruejo E, et al. Ann Pharmacother. 2011 Jul;45(7-8):e43. doi: 10.1345/aph.1Q035. Epub 2011 Jun 13. Ann Pharmacother. 2011. PMID: 21672886

6

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ridruejo E, Adrover R, Silva MO. Ridruejo E, et al. Hepatology. 2011 Sep 2;54(3):1104-5; author reply 1105. doi: 10.1002/hep.24498. Hepatology. 2011. PMID: 21721024 No abstract available.

7

Effectiveness of entecavir in chronic hepatitis B NUC-naive patients in routine clinical practice.

Ridruejo E, Adrover R, Cocozzella D, Reggiardo MV, Estepo C, Schroder T, Paz S, Mendizábal M, Fainboim H, Mandó OG, Silva MO. Ridruejo E, et al. Int J Clin Pract. 2011 Aug;65(8):866-70. doi: 10.1111/j.1742-1241.2011.02719.x. Int J Clin Pract. 2011. PMID: 21762311

8

Genetic variation in interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin.

Ridruejo E, Solano A, Marciano S, Galdame O, Adrover R, Cocozzella D, Delettieres D, Martínez A, Gadano A, Mandó OG, Silva MO. Ridruejo E, et al. Ann Hepatol. 2011 Oct-Dec;10(4):452-7. Ann Hepatol. 2011. PMID: 21911885 Free article.

9

Entecavir in the treatment of chronic hepatitis B in kidney transplantation.

Ridruejo E, Adrover R, Mandó OG, Silva MO. Ridruejo E, et al. J Hepatol. 2012 Apr;56(4):997-8; author reply 999. doi: 10.1016/j.jhep.2011.09.019. Epub 2011 Nov 7. J Hepatol. 2012. PMID: 22075262 Free article. No abstract available.

10

Safety of long-term nucleos(t)ide treatment in chronic hepatitis B.

Ridruejo E, Silva MO. Ridruejo E, et al. Expert Opin Drug Saf. 2012 May;11(3):357-60. doi: 10.1517/14740338.2012.672972. Epub 2012 Mar 15. Expert Opin Drug Saf. 2012. PMID: 22417072

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters